Cytochrome P450 isozymes and antiepileptic drug interactions.
about
Role of cytochrome P450 in drug interactionsInhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3AThe effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteersChloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomesPharmacokinetic drug-drug interaction and their implication in clinical managementIn vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6Potential fluconazole-induced carbamazepine toxicitySummary of information on human CYP enzymes: human P450 metabolism data.Possible acute thrombocytopenia post esomeprazole and hydantoin coadministration.Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.Pharmacogenetic screening for susceptibility to fetal malformations in women.Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy.A mechanistic approach to antiepileptic drug interactions.The use of antidepressant and antipsychotic drugs in elderly epilepsy patients.Cellular localization and functional significance of CYP3A4 in the human epileptic brain.Clinically relevant genetic variations in drug metabolizing enzymes.Effect of status epilepticus and antiepileptic drugs on CYP2E1 brain expressionSertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.Topiramate and its clinical applications in epilepsy.Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports.Pharmacogenetics of analgesics: toward the individualization of prescription.Cytochrome P450 2C9-CYP2C9.Influence of efflux transporters on drug metabolism: theoretical approach for bioavailability and clearance prediction.The cytochrome P450 pathway in angiogenesis and endothelial cell biology.Anti-epileptic drugs and hormonal treatments.Vaccine-Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms.Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flowBiomarkers for antiepileptic drug response.Important pharmacokinetic properties of antiepileptic drugs.The effect of age on pharmacokinetics of antiepileptic drugs.Antidepressants: knowledge and use among nursing students.Phenytoin and fluorouracil interaction.Probable metabolic interaction of doxifluridine with phenytoin.Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.Diosmin pretreatment affects bioavailability of metronidazole.Influence of CYP2C9 genotypes on the formation of a hepatotoxic metabolite of valproic acid in human liver microsomes.Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures.Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.Drug-drug interactions as a result of co-administering Δ9-THC and CBD with other psychotropic agents.
P2860
Q21245066-989DAE33-29F1-4B53-8BA0-2B4F8C4159CDQ24550617-85D719E9-9F68-45A7-9CC9-F5988F1561E5Q24564995-0CFBBDCA-5D9B-45DE-B40D-6C06B95B2516Q24650578-866577F2-4F77-4109-8666-189D4812448BQ27021051-CFA95179-0AFD-43CA-8824-AB96CBECB3AEQ28344127-24737979-C128-4F7B-910F-8CE531248822Q28371958-F1FEF62D-D8C6-43EE-9818-38F45528F868Q32103802-531EBCB0-C466-4203-AF3E-0AFBC1F5B057Q33394984-B06ABC5A-44F9-4862-9C7C-63C640F31627Q33668831-F89DC482-ACD1-4EB8-B9EB-2573A82794B2Q33941950-F42A7F85-ACA3-440B-968E-BD43A66053EEQ33999449-DDB8F39E-32B1-4A49-AF6E-C51751629A5DQ34469990-108875DF-6FEC-437B-9C2D-352E05E59591Q34570611-0954C16D-A769-4E7D-B70A-F38B3A3FD207Q34669448-2C92A173-BBD4-4DDB-9718-7EF522F31F63Q35032378-2AEDDF99-7486-4B19-8B1D-FFAC242AE10DQ35252029-EC3BD6E8-9496-4C90-95EB-58D4F367B357Q35551134-E1302105-BF61-4EC9-A43F-769AAC7FD3C3Q36429751-A70C12C3-2771-4DA9-98B0-AD1A46838A1EQ36648263-0C21B1F3-2A00-4B0C-ADC6-70C13BE6CBDCQ37205954-C0968F87-6208-4813-92DF-90A8C7D7114DQ37691210-8108CD98-D17D-43B1-86C4-2710B9EB921BQ37829421-6B0B0E6E-87DD-42B2-AD7B-27D80085D00BQ37947082-A8303EF8-9D82-4364-B112-D6DC533F5D7EQ38200537-FB6A8965-9BFF-42B4-BABB-57EAA68C383FQ38560295-741CEC84-F157-4168-9FBF-8BDE1AB82AF4Q39752034-A5BD0BA4-0E1E-407C-BF3B-F9C9F2C46EBFQ40575037-21CCCF25-1176-4C7D-875B-0CF29B4B8F4BQ41112028-B95F9C49-9FAD-433A-9063-BB28AE6DD3CBQ41112035-20A815F8-0234-4F42-93F6-D723C3285B85Q42933195-02FBC3A0-A75B-4F77-8332-EF34FCF57397Q43809478-2CC1CDC8-9904-49A1-ABD6-41AC872CBAE4Q43972195-F31D8A04-4DE3-4FE6-BEE5-327B762B6BDAQ44354993-585EA325-569D-4B82-A5A1-9C14734B1BDBQ44383228-566E150F-4B17-4DEE-9637-1FD8A376943FQ44405613-9914E93C-4935-4AD7-B831-55530E3D06C1Q44642230-E4EA847D-FCB0-4E2A-82AB-0FA954FF6EE4Q47417355-8A7845D1-E58C-45B1-9282-FA6DD050BDA2Q47570862-3AC2D919-3058-453E-80E6-F2C3EC19853BQ47589227-0B60F72A-B45D-4C84-94EA-A1E491439AF3
P2860
Cytochrome P450 isozymes and antiepileptic drug interactions.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Cytochrome P450 isozymes and antiepileptic drug interactions.
@en
type
label
Cytochrome P450 isozymes and antiepileptic drug interactions.
@en
prefLabel
Cytochrome P450 isozymes and antiepileptic drug interactions.
@en
P2860
P1433
P1476
Cytochrome P450 isozymes and antiepileptic drug interactions.
@en
P2093
P2860
P356
10.1111/J.1528-1157.1995.TB06007.X
P478
36 Suppl 5
P577
1995-01-01T00:00:00Z